Penelope Ottewell
3 months ago
PhD Studentship in Precision Therapies for Prostate Cancer University of Sheffield in United Kingdom
Degree Level
PhD
Field of study
not provided
Funding
Available
Deadline
Expired
Country
United Kingdom
University
University of Sheffield

How do Indian students apply for this?
Sign in for free to reveal details, requirements, and source links.
Where to contact
About this position
A new PhD studentship is available through a collaboration between Newcastle University, The University of Sheffield, and industry partners. This opportunity is ideal for UK students interested in developing advanced, precision therapies targeting prostate cancer. The project will likely involve interdisciplinary research at the intersection of cancer biology and therapeutic development, with access to expertise and resources from both academic institutions and industry collaborators. The studentship is supervised by Professor Penelope Ottewell, a leading expert in cancer biology at the University of Sheffield. While specific funding details and application requirements are not provided in the announcement, interested candidates are encouraged to follow the provided link for further information and to apply. This position offers a unique chance to contribute to cutting-edge research in cancer therapy within a supportive and innovative environment.
Funding details
Available
What's required
Applicants must be UK students with an interest in developing state-of-the-art precision therapies for prostate cancer. No further details on degree background, skills, or other requirements are provided.
How to apply
Follow the provided link for more information and application instructions. Prepare your application materials as specified on the linked page.
Ask ApplyKite AI
Start chatting
Can you summarize this position?
What qualifications are required for this position?
How should I prepare my application?
Professors

How do Indian students apply for this?
Sign in for free to reveal details, requirements, and source links.